Paul Emery

Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials

Ronald van Vollenhoven, Paul Emery, Clifton O. Bingham et al. · The Journal of Rheumatology · 2010 · 286 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +17

Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies

Edward Keystone, Paul Emery, Charles Peterfy et al. · Annals of the Rheumatic Diseases · 2008 · 240 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period

Paul Emery, Gerd R Burmester, Vivian P. Bykerk et al. · Annals of the Rheumatic Diseases · 2014 · 238 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +16

Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission: the COMET trial

J. Kekow, Robert J. Moots, Paul Emery et al. · Annals of the Rheumatic Diseases · 2009 · 126 citations

Medicine, Clinical Sciences, Pharmacotherapy +15

Local and systemic glucocorticoid metabolism in inflammatory arthritis

Rowan Hardy, Elizabeth Rabbitt, Andrew Filer et al. · Annals of the Rheumatic Diseases · 2008 · 116 citations · Full text

Medicine, Biochemistry, Endocrinology +14